Blunt Roshawn A. 4
4 · Reneo Pharmaceuticals, Inc. · Filed Jun 8, 2023
Insider Transaction Report
Form 4
Blunt Roshawn A.
Director
Transactions
- Award
Stock Option (right to buy)
2023-06-06+14,815→ 14,815 totalExercise: $9.01Exp: 2033-06-05→ Common Stock (14,815 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest on the earlier of June 6, 2024 or the day prior to the date of the Issuer's 2024 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors.